Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
No controlled human-lifespan evidence exists
Phase 2/3 trial of structurally distinct prodrug fosgonimeton (Athira ATH-1017) missed primary endpoint in 2023 Product Specifications Format: capsules Strength: 10 mg per capsule Count: 30 capsules per bottle Purity: 98% (HPLC verified) Container: sealed amber bottle Certificate of Analysis: lot-specific COA available See the FDA Disclosure, Storage Instructions, and RUO tabs for handling, storage, and regulatory information
Peptide BPC-157 exhibits both preventive and mitigating nephroprotective effects
While GLP-1 drugs like semaglutide or tirzepatide boost insulin secretion and reduce glucagon, cagrilintide primarily slows gastric emptying and suppresses appetite via amylin receptors
US$ 27.12
US$ 27.44
US$ 20.69
US$ 23.79
